NLNK : Summary for NewLink Genetics Corporation - Yahoo Finance

U.S. Markets close in 1 hr 53 mins

NewLink Genetics Corporation (NLNK)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
19.20+1.12 (+6.19%)
As of 2:05PM EDT. Market open.
People also watch
TKMRCMRXSRPTCLVSPTCT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close18.08
Open18.16
Bid19.15 x 100
Ask19.17 x 100
Day's Range18.11 - 19.42
52 Week Range9.23 - 25.17
Volume430,801
Avg. Volume596,482
Market Cap561.01M
Beta2.42
PE Ratio (TTM)-6.53
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    NewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : April 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives NewLink Genetics Corp. a score of 14. Our analysis is based on comparing NewLink Genetics Corp. with the following peers – Eli Lilly and Company, Threshold Pharmaceuticals, Inc., Pfizer Inc., Sarepta Therapeutics, Inc., SIGA Technologies Inc, Johnson & Johnson, Sinovac Biotech Ltd. and Bristol-Myers Squibb Company (LLY-US, ... Read more (Read more...)

  • Should Gilead Sciences Acquire NewLink Genetics?
    Motley Fool3 days ago

    Should Gilead Sciences Acquire NewLink Genetics?

    NewLink Genetics intriguing IDO-inhibitors could make it a target of Gilead Sciences.

  • GlobeNewswire3 days ago

    NewLink Genetics Announces Presentation of Two Abstracts at ASCO

    AMES, Iowa, April 21, 2017-- NewLink Genetics Corporation, a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported that two abstracts will ...